Literature DB >> 3082511

Childhood neurofibromatosis: risk factors for malignant disease.

M Schneider, A C Obringer, E Zackai, A T Meadows.   

Abstract

Forty-five children with both neurofibromatosis and malignant tumors were compared with a pediatric population with neurofibromatosis without tumors to ascertain if any of the clinical manifestations of this disorder were associated with either tumor development or histology. No such factors emerged except that, in most of the optic glioma patients, the neurofibromatosis mutation was paternally inherited. Concordance of histologic tumor types was seen when malignancies occurred in affected family members, similar to that noted in the literature. Although cancer is independent of the other manifestations of neurofibromatosis and these manifestations may vary among family members, it appears that malignant tumors are often concordant when they occur within a family.

Entities:  

Mesh:

Year:  1986        PMID: 3082511     DOI: 10.1016/0165-4608(86)90216-5

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

Review 1.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

2.  Intestinal pseudo-obstruction in myotonic dystrophy.

Authors:  H G Brunner; B C Hamel; P Rieu; C J Höweler; F T Peters
Journal:  J Med Genet       Date:  1992-11       Impact factor: 6.318

3.  Late effects of early childhood cancer therapy.

Authors:  A T Meadows; J A Gallagher; G R Bunin
Journal:  Br J Cancer Suppl       Date:  1992-08

4.  Mortality associated with neurofibromatosis type 1: a study based on Italian death certificates (1995-2006).

Authors:  Maria Masocco; Yllka Kodra; Monica Vichi; Susanna Conti; Mark Kanieff; Monica Pace; Luisa Frova; Domenica Taruscio
Journal:  Orphanet J Rare Dis       Date:  2011-03-25       Impact factor: 4.123

5.  A case of non-Hodgkin's lymphoma in a patient with neurofibromatosis type 1.

Authors:  Seok Jin Kim; Jae Hong Seo; Sang Woo Lee; Eunmee Han; Eung Seok Lee; Sang Hoon Cha; Bo Kyoung Seo
Journal:  Korean J Intern Med       Date:  2003-09       Impact factor: 2.884

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.